On #InternationalWomensDay, we proudly celebrate the incredible women of Healx who are driving innovation and advancing our mission to harness the power of #AI to deliver life-changing treatments to #raredisease patients. Your passion, expertise, and dedication inspire us every day. Thank you for all that you do! #IWD2025
Healx
Biotechnology Research
Cambridge, Cambridgeshire 18,926 followers
AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.
About us
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are more than 10,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
- Website
-
http://www.healx.ai
External link for Healx
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Privately Held
- Founded
- 2014
Locations
-
Primary
Get directions
66-68 Hills Rd
Charter House
Cambridge, Cambridgeshire CB21LA, GB
Employees at Healx
Updates
-
From a shared vision to changing lives! Hear from our co-founder, David Brown, as he takes us back to 2013 — the moment he first met our co-founder and CEO, Tim Guilliams, PhD. That conversation sparked an idea, which soon grew into Healx — and set us on a mission to transform how rare diseases are treated through a bold, technology-driven approach to drug discovery and development. Fast forward to today, and we’ve just dosed the first patient in our Phase 2 trial for HLX-1502, an oral investigational therapy for neurofibromatosis type 1 (#NF1). Watch Dr. Brown reflect on our journey — from the very first patient stories that inspired us, to this exciting milestone — and learn more about our progress here: https://lnkd.in/eNBTftKW #RareDisease #NF1 #Biotech #DrugDevelopment #PatientDrivenInnovation
-
Tomorrow is #RareDiseaseDay — a day to recognise the millions people worldwide living with rare diseases. 95% of rare diseases have no approved treatment options. Here at Healx, we’re committed to changing that — driving innovation and collaboration to deliver new treatment options for the #raredisease community. Learn how you can make a difference: https://lnkd.in/gk6hbAF #RareDisease #RareDiseaseAwareness #Advocacy #PatientVoices
Imagine the population of the 3rd largest country in the world. 🌎 Imagine every man, woman, person and child in that country. 🧑🏿🤝🧑🏿 And now imagine every single one of them was living with a rare disease. On #RareDiseaseDay, we aim to highlight the voices of every one of these people and raise awareness about their experiences. Ultimately, giving the rare disease community a platform to share their experiences allows us to generate change and catalyse the process of achieving equity. Download our Infographics: https://lnkd.in/efRbDevB
-
-
🚀 Milestone Moment! 🚀 We’re thrilled to announce that the first patient has been dosed in INSPIRE-NF1, our Phase 2 study evaluating HLX-1502 in patients with #Neurofibromatosis Type 1 (#NF1)—a rare genetic disorder affecting ~1 in 2,500 people worldwide and associated with the risk of multiple benign and malignant tumors. This marks a critical step forward in our mission to harness #AI and cutting-edge technology to accelerate breakthroughs for #raredisease patients. Hear from our co-founder and CEO, Tim Guilliams, Ph.D., as he shares why this trial is a major milestone in bringing innovation and hope to the NF1 community. Read more on our website: https://lnkd.in/eNBTftKW #NF1Awareness #Biotech #Innovation #AIforGood #RareDiseases
-
In honor of International Day of Women and Girls in Science, we’re celebrating the incredible women at Healx who are helping to pave the way in AI-driven drug discovery for #rarediseases. We believe in fostering a more inclusive future where women and girls are empowered to shape the next breakthroughs in science and technology, we’re proud to support a workplace where diverse perspectives drive progress and impact. #IDWGS #WomenInScience
-
Exciting news! Our CEO, Tim Guilliams, joined the Global Genes RARECast podcast to discuss the unique ways Healx is leveraging #AI to revolutionise drug discovery for #rarediseases, starting with neurofibromatosis type 1 (#NF1). 🎙️ In this episode, Tim delves into: 🔹 Healx’s origins and mission 🔹 Our progress to date in rare disease treatment 🔹 His insights on AI’s trans-formative role in healthcare 💡 Don’t miss this conversation on innovation and impact in biotech! Listen now: https://lnkd.in/dvfeEuZq
-
-
We’re thrilled to be heading to the J.P. Morgan Healthcare Conference in San Francisco next week, connecting with #biotech leaders and industry experts as we work toward our mission of transforming lives for #raredisease patients through our generative #AI approach. Our CEO, Tim Guilliams, will be attending—if you see him, don’t hesitate to say hello! We’re always excited to share insights and explore collaborations that can accelerate innovation in healthcare. Here’s to an inspiring and impactful #JPM25! #HealthcareInnovation
-
-
Another quarterly team days meeting in the books! We enjoyed coming together in Cambridge one final time before the end of the year to reflect on the progress made in 2024 and the strides we have made in leveraging the power of generative AI to bring new treatments to patients. Our advancements wouldn’t be possible without the dedication and passion of this talented team and the partnerships we’ve fostered with organisations and collaborators around the world. And to top it all off, even Father Christmas stopped by to celebrate the season and the team’s hard work!
-
-
Our co-founder and CEO Tim Guilliams is looking forward to participating in a panel discussion on how #AI is reshaping healthcare at Balderton Capital’s “From code to cure: AI's reshaping of drug discovery” event in London. Tim will highlight how Healx is leveraging generative AI to build a pipeline of patient-inspired treatments for #rarediseases. Learn more about the private event here: https://lnkd.in/eZAe2BB8
-
-
We are pleased to announce the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. Dr. Milner is a distinguished entrepreneur and an influential figure in the UK life sciences and #biotech industry with a strong track record of fostering innovation. In addition to serving on several boards, he has contributed his expertise to numerous startups and established organisations, and we are grateful to have him at Healx. This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. Dr. Brown will remain an active member of the Healx board, continuing to contribute and support Tim Guilliams, Ph.D., co-founder and CEO of Healx, and Dr. Milner in advancing Healx’s mission. Read more about this update here: https://lnkd.in/eQf2TvQx
-